Whither surgical quality assurance of breast cancer surgery (surgical margins and local recurrence) after paterson N. J. BundredJ. ThomasJ. M. J. Dixon Editorial 05 July 2017 Pages: 473 - 475
Preoperative paravertebral blocks for the management of acute pain following mastectomy: a cost-effectiveness analysis Anaeze C. Offodile IIClifford C. SheckterWilliam V. Padula Review 04 July 2017 Pages: 477 - 484
Reviewing the quality, health benefit and value for money of chemotherapy and targeted therapy for metastatic breast cancer Xavier Ghislain Léon Victor PouwelsBram L. T. RamaekersManuela A. Joore Review Open access 08 July 2017 Pages: 485 - 498
Predictive factors on outcomes in metaplastic breast cancer C. Marc LeyrerCamille A. BerriochoaRahul D. Tendulkar Review 08 July 2017 Pages: 499 - 504
A step-by-step oncoplastic breast conservation surgical atlas of reproducible dissection techniques and anatomically ideal incision placement Sunny D. Mitchell Preclinical study 28 June 2017 Pages: 505 - 516
Pro-apoptotic effect of Δ2-TGZ in “claudin-1-low” triple-negative breast cancer cells: involvement of claudin-1 Marine GeoffroyAlexandra KleinclaussSandra Kuntz Preclinical study 05 July 2017 Pages: 517 - 527
Erratum to: Pro-apoptotic effect of Δ2-TGZ in “claudin-1-low” triple-negative breast cancer cells: involvement of claudin-1 Marine GeoffroyAlexandra KleinclaussSandra Kuntz Erratum 31 July 2017 Pages: 529 - 529
New FTY720-docetaxel nanoparticle therapy overcomes FTY720-induced lymphopenia and inhibits metastatic breast tumour growth Heba AlshakerQi WangDmitri Pchejetski Preclinical study Open access 10 July 2017 Pages: 531 - 543
Does biomarker information impact breast cancer patients’ preferences and physician recommendation for adjuvant chemotherapy? Ann H. PartridgeKaren SepuchaBryan P. Schneider Clinical trial 23 June 2017 Pages: 545 - 553
Different outcome in node-positive breast cancer patients found by axillary ultrasound or sentinel node procedure Nicole C. VerheuvelAdri C. VoogdRudi M. H. Roumen Clinical trial Open access 27 June 2017 Pages: 555 - 563
Mammographic breast density decreases after bariatric surgery Austin D. WilliamsAlycia SoJulia Tchou Clinical trial 28 June 2017 Pages: 565 - 572
Reducing chemotherapy use in clinically high-risk, genomically low-risk pN0 and pN1 early breast cancer patients: five-year data from the prospective, randomised phase 3 West German Study Group (WSG) PlanB trial Ulrike NitzOleg GluzNadia Harbeck Clinical trial Open access 29 June 2017 Pages: 573 - 583
A pilot study of cabergoline for the treatment of metastatic breast cancer Ricardo CostaC. A. Santa-MariaV. G. Kaklamani Clinical Trial 03 July 2017 Pages: 585 - 592
Improved survival for sequentially as opposed to concurrently delivered neoadjuvant chemotherapy in non-metastatic breast cancer B. E. P. J. VriensI. J. H. Vrienson behalf of the Breast Cancer Trialists’ Group of the Netherlands (BOOG) Clinical trial Open access 03 July 2017 Pages: 593 - 600
A randomized phase II trial of ridaforolimus, dalotuzumab, and exemestane compared with ridaforolimus and exemestane in patients with advanced breast cancer Hope S. RugoOlivier TrédanJosé Baselga Clinical trial 05 July 2017 Pages: 601 - 609
Prognostic impact of the inclusion of uPA/PAI-1 for adjuvant treatment decision-making in ER+/Her2− pN0 early breast cancers Marie VialaMarie AlexandreSeverine Guiu Clinical trial 06 July 2017 Pages: 611 - 621
Association between lifestyle, menstrual/reproductive history, and histological factors and risk of breast cancer in women biopsied for benign breast disease Rhonda ArthurYihong WangThomas Rohan Epidemiology 22 June 2017 Pages: 623 - 631
The effect of 14-3-3ζ expression on tamoxifen resistance and breast cancer recurrence: a Danish population-based study Jake E. ThistleYlva HellbergTimothy L. Lash Epidemiology 22 June 2017 Pages: 633 - 643
Androgen receptor expression and breast cancer mortality in a population-based prospective cohort Karin ElebroPär-Ola BendahlSigne Borgquist Epidemiology Open access 22 June 2017 Pages: 645 - 657
Variable aromatase inhibitor plasma concentrations do not correlate with circulating estrogen concentrations in post-menopausal breast cancer patients Daniel L. HertzKelly A. SpethJames M. Rae Epidemiology 22 June 2017 Pages: 659 - 668
Increasing utilization of regional nodal irradiation in elderly node-positive women and declining emphasis on demographic factors Jason K. MolitorisTejan DiwanjiSteven J. Feigenberg Epidemiology 23 June 2017 Pages: 669 - 676
Cognitive function and discontinuation of adjuvant hormonal therapy in older breast cancer survivors: CALGB 369901 (Alliance) Shirley M. BluethmannCatherine M. AlfanoJeanne S. Mandelblatt Epidemiology 26 June 2017 Pages: 677 - 686
Prevalence and spectrum of germline rare variants in BRCA1/2 and PALB2 among breast cancer cases in Sarawak, Malaysia Xiaohong R. YangBeena C. R. DeviMichael Dean Epidemiology 29 June 2017 Pages: 687 - 697
The effects of physical activity and fatigue on cognitive performance in breast cancer survivors Diane K. EhlersSusan AguiñagaEdward McAuley Epidemiology 04 July 2017 Pages: 699 - 707
Patterns and predictors of first and subsequent recurrence in women with early breast cancer Y. M. GeurtsA. WitteveenS. Siesling Epidemiology Open access 04 July 2017 Pages: 709 - 720
Persistent impairments 3 years after (neo)adjuvant chemotherapy for breast cancer: results from the MaTox project Hans-Jürgen HurtzHans TeschTMK-Group (Tumour Registry Breast Cancer) Epidemiology Open access 05 July 2017 Pages: 721 - 731
Prognostic values of cancer associated macrophage-like cells (CAML) enumeration in metastatic breast cancer Zhaomei MuChun WangMassimo Cristofanilli Epidemiology 07 July 2017 Pages: 733 - 741
Risk of mortality of node-negative, ER/PR/HER2 breast cancer subtypes in T1, T2, and T3 tumors Carol A. PariseVincent Caggiano Epidemiology 08 July 2017 Pages: 743 - 750
Oncologists’ influence on receipt of adjuvant chemotherapy: does it matter whom you see for treatment of curable breast cancer? Steven J. KatzSarah T. HawleyAllison W. Kurian Epidemiology 08 July 2017 Pages: 751 - 756
Impact of the 21-gene recurrence score on outcome in patients with invasive lobular carcinoma of the breast Scott KizyJing Li HuangJane Yuet Ching Hui Brief Report 24 June 2017 Pages: 757 - 763
Detection of BRCA1 gross rearrangements by droplet digital PCR Elena V. PreobrazhenskayaIlya V. BizinAnna P. Sokolenko Brief Report 27 June 2017 Pages: 765 - 770
From clinical trials to clinical practice: outcome of NSABP-B27 neoadjuvant chemotherapy regimen for high-risk early-stage breast cancer Hikmat Abdel-RazeqLina MareiAyat Taqash Brief Report 30 June 2017 Pages: 771 - 777
In response to “outcomes of patients with inflammatory breast cancer treated by breast conserving surgery”: the argument against breast conservation and sentinel lymph node biopsy in IBC Kelly J. RossoNaoto T. UenoAnthony Lucci Letter to the Editor 03 July 2017 Pages: 779 - 781
Response Letter M. BrezezinskaL. J. WilliamsJ. M. Dixon Rebuttal Letter 11 July 2017 Pages: 783 - 784
